These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 29212715)

  • 41. From precursors to myelinating oligodendrocytes: contribution of intrinsic and extrinsic factors to white matter plasticity in the adult brain.
    Boulanger JJ; Messier C
    Neuroscience; 2014 Jun; 269():343-66. PubMed ID: 24721734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel microtubule-associated protein-2 expressed in oligodendrocytes in multiple sclerosis lesions.
    Shafit-Zagardo B; Kress Y; Zhao ML; Lee SC
    J Neurochem; 1999 Dec; 73(6):2531-7. PubMed ID: 10582615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activin receptors regulate the oligodendrocyte lineage in health and disease.
    Dillenburg A; Ireland G; Holloway RK; Davies CL; Evans FL; Swire M; Bechler ME; Soong D; Yuen TJ; Su GH; Becher JC; Smith C; Williams A; Miron VE
    Acta Neuropathol; 2018 Jun; 135(6):887-906. PubMed ID: 29397421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differentiation of oligodendrocyte progenitor cells from dissociated monolayer and feeder-free cultured pluripotent stem cells.
    Yamashita T; Miyamoto Y; Bando Y; Ono T; Kobayashi S; Doi A; Araki T; Kato Y; Shirakawa T; Suzuki Y; Yamauchi J; Yoshida S; Sato N
    PLoS One; 2017; 12(2):e0171947. PubMed ID: 28192470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TCF7l2, a nuclear marker that labels premyelinating oligodendrocytes and promotes oligodendroglial lineage progression.
    Guo F; Wang Y
    Glia; 2023 Feb; 71(2):143-154. PubMed ID: 35841271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The adult oligodendrocyte can participate in remyelination.
    Duncan ID; Radcliff AB; Heidari M; Kidd G; August BK; Wierenga LA
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11807-E11816. PubMed ID: 30487224
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Revisiting Notch in remyelination of multiple sclerosis lesions.
    Brosnan CF; John GR
    J Clin Invest; 2009 Jan; 119(1):10-3. PubMed ID: 19104146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms of remyelination: recent insight from experimental models.
    Tanaka T; Yoshida S
    Biomol Concepts; 2014 Aug; 5(4):289-98. PubMed ID: 25372760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laquinimod Supports Remyelination in Non-Supportive Environments.
    Nyamoya S; Steinle J; Chrzanowski U; Kaye J; Schmitz C; Beyer C; Kipp M
    Cells; 2019 Oct; 8(11):. PubMed ID: 31683658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination.
    Chen Y; Zhen W; Guo T; Zhao Y; Liu A; Rubio JP; Krull D; Richardson JC; Lu H; Wang R
    PLoS One; 2017; 12(12):e0189380. PubMed ID: 29253893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
    Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
    J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion.
    Raine CS; Scheinberg L; Waltz JM
    Lab Invest; 1981 Dec; 45(6):534-46. PubMed ID: 7321526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors.
    Gautier HO; Evans KA; Volbracht K; James R; Sitnikov S; Lundgaard I; James F; Lao-Peregrin C; Reynolds R; Franklin RJ; Káradóttir RT
    Nat Commun; 2015 Oct; 6():8518. PubMed ID: 26439639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential activity of transcription factor Sox9 in early and adult oligodendroglial progenitor cells.
    Hassel LA; Fröb F; Küspert M; Hillgärtner S; Arnold P; Huang W; Kirchhoff F; Wegner M
    Glia; 2023 Aug; 71(8):1890-1905. PubMed ID: 37017184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of Unconventional Myosin VI in Oligodendrocytes.
    Yamazaki R; Ishibashi T; Baba H; Yamaguchi Y
    Neurochem Res; 2017 Dec; 42(12):3372-3381. PubMed ID: 28828543
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE; Kuhlmann T; Antel JP
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conditional Deletion of the L-Type Calcium Channel Cav1.2 in NG2-Positive Cells Impairs Remyelination in Mice.
    Santiago González DA; Cheli VT; Zamora NN; Lama TN; Spreuer V; Murphy GG; Paez PM
    J Neurosci; 2017 Oct; 37(42):10038-10051. PubMed ID: 28899915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Remyelination alters the pattern of myelin in the cerebral cortex.
    Orthmann-Murphy J; Call CL; Molina-Castro GC; Hsieh YC; Rasband MN; Calabresi PA; Bergles DE
    Elife; 2020 May; 9():. PubMed ID: 32459173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Connexins in oligodendrocytes and astrocytes: Possible factors for demyelination in multiple sclerosis.
    Xia CY; Xu JK; Pan CH; Lian WW; Yan Y; Ma BZ; He J; Zhang WK
    Neurochem Int; 2020 Jun; 136():104731. PubMed ID: 32201280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.